The development of the Russian pharmaceutical industry became an important topic of conversation between the Chairman of the state Duma V. Volodin and the head of "Business Russia" A. Repik. In particular, they discussed measures that could help reduce prices for medicines for citizens, the press service of the state Duma reported. "The availability and quality of medicines is a priority for both the DG and the business community," Repik said. The issues of protection of the rights of domestic companies - innovators who create new medicines,and the fight against counterfeit drugs were also raised.Pharmaceutical Bulletin, 31.05.2018, " ALEXEY REPIK: RUSSIAN PATIENTS should get "BREAKTHROUGH THERAPY FASTER»